Gut Decolonisation With Neomycin/Metronidazole or Rifaximin Before Colon Surgery

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversität Luzern

About this trial

The goal of this clinical trial is to find out if a gut cleaning using Rifaximin works as well as the usual treatment with Neomycin and Metronidazole to prevent infections after colon surgery. The study includes adult patients who will have colon surgery.

The main question it aims to answer are:

-Does the Rifaximin treatment prevent surgical site infections as well as the Neomycin/Metronidazole treatment?

Other things the study will look at:

* How often infections happen, stratified on how deep they are, the type of surgery the patients got, or if bowel cleaning was done before surgery. * How many people will die after surgery * How long people stay in hospital

Participants will:

* Take either Rifaximin or Neomycin/Metronidazole one day before surgery to clean their gut * Keep a diary until the surgery to record medication intake and any side effects * Be contacted by phone 30 days after surgery to ask about their condition and any side effects,

Eligibility criteria

Qualifiers

aged ≥ 18 years

undergoind planned colon surgery

colon surgery will be included in Swissnoso SSI surveillance

informed consent

Disqualifiers

contraindications and/or intolerance to one of the study compounds

patients with underlying active infection (wound contamination class IV) at the timepoint of incision

pregnant women

unable to follow study protocol

Trial design

Treatments tested in this trial

  • Rifaximin (Xifaxan)
  • Metronidazole
  • Neomycin Sulfate

Treatment groups

458 Participants
are divided into 2 treatment groups

Sponsors and collaborators